Latest Hydroxyethyl starch Stories
MarketPublishers.com announces that a new research report on the hydroxyethyl starch (CAS 9005-27-0) market prepared by BAC Reports is available in its catalogue. London,
Starch-based intravenous (IV) fluids used by the NHS to treat seriously ill patients are causing unnecessary deaths.
In an analysis of studies that examined critically ill patients requiring an increase in blood fluid volume, intravenous use of the fluid hydroxyethyl starch, compared with other resuscitation solutions, was not associated with decreased mortality.
BAD HOMBURG, Germany and LACHEN, Switzerland, Oct.